WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB: ILIU) today announced the appointment of Lynn Doucette-Stamm, Ph.D., as Vice President of Development. In this role, Dr. Doucette-Stamm will supervise the operational activities of the Company’s on-going clinical studies and development of genetic tests.
